 |
|
|
Health
2000 1999
1998 1997 1996
1995
Documents from
2001 to 2003 (click)
2000
A
Briefing on TRIPS, 2000.
Author: World Health Organization, Regional Office for the
Western Pacific, Manila.
Access
to essential medicines in developing countries: does the WTO TRIPS
Agreement hinder it?, 2000
Author: J. Watal / Science, Technology and Development
Discussion Paper, No. 8.
A
patent policy proposal for global diseases, 2000.
J. Olson Lanjouw.
Drug
patents in French-speaking Africa, 2000.
P. Boulet, Gilles-Bernard Forte / Unofficial translation
of the MSF-WHO-UNAIDS report, Joint Mission MSF-OMS-ONUSIDA, Cameroun,
6-10 February 2000.
Drug
pricing [in South Africa], 2000.
Authors: A. Gray, T. Matsebula / South African Healt Review
2000, Briefing Summary, Health Systems Trust.
El
ABC del Patentamiento de la Vida, 2000.
Genetic Resources Action International (GRAIN).
El
Sistema de Patentes en Crisis? Practicas de Patentamiento Farmaceutico,
2000.
Carlos Correa.
Essential Drugs in Southern
Africa Need Protection from Public Health Safeguards under TRIPS,
2000.
R. Loewenson / BRIDGES, ICTSD, Vol. 4, N°7,
September 2000.
Global
trade and health: key linkages and future challenges, 2000.
Authors: Douglas W. Bettcher, Derek Yach, G. Emmanuel Guindon
/ Bulletin of the World Health Organization, Vol. 78, N°4.
How
Stronger Patent Protection in India might affect the Behavior of
Transnational Pharmaceutical Industries, 2000.
Carsten Fink / Policy Research Working Paper,
The World Bank Development Research Group, N°2352.
Integrating
Public Health Concerns into Patent Legislation in Developing Countries,
2000.
C. Correa / South Centre.
Patent
Law and Its Application to the Pharmaceutical Industry: An Examination
of the Drug Price Competition and Patent Term Extension Act of 1984.,
2000.
Authors: W. Schacht, J. Thomas / Congressional Research
Service Documents, Washington, D.C., USA.
Patent
Protection and Access to HIV/AIDS Pharmaceuticals in Sub-Saharan
Africa., 2000.
Authors: Lee Gillespie-White, Venus Griffith, Albena Petrova,
Stetson Sanders, Paul Salmon / International Intellectual Property
Institute (IIPI).
Patent
situation of HIV/AIDS-related drugs in 80 countries, 2000.
Authors: P. Boulet, J. Perriens, F. Renaud-Théry /
Joint UNAIDS/WHO publication.
Pharmaceuticals
and the WTO TRIPS Agreement: Questions and Answers, 2000.
Authors: P. Boulet, J. Perriens, F. Renaud-Théry,
G. Velasquez / Joint UNAIDS/WHO publication.
Report
of the Inter-Regional Workshop on Intellectual Property Rights in
the Context of Traditional Medicine, 2000.
World Health Organisation (WHO) / Bangkok, Thailand,
6–8 December 2000.
The
Pharmaceutical Industry and World Intellectual Property Standards,
2000.
F. M. Scherer / Vanderbilt Law Review, Vol.
53, N°6.
The Canadian
Generic Medicines Panel A Dangerous Precedent in Dangerous Times,
2000.
R. Howse / BRIDGES, ICTSD, Vol. 4, N°3,
April 2000.
The
Long Shadow of Patent Expiration: Do RX to OTC Switches Provide
an Afterlife?, 2000.
Authors: Ernst R. Berndt, Davina Ling and Margaret K. Kyle
/ paper presented at the National Bureau of Economic Research -
Conference on Research in Income and Wealth, Symposium on Scanner
Data and Price Indexes, Arlington, Virginia, September 15-16, 2000.
The
TRIPS Agreement and pharmaceuticals: report of the ASEAN workshop
on the TRIPS agreement and its impact on pharmaceuticals, 2000.
Authors: K. Timmermans, T. Hutadjulu / Directore General
of Drug and Food Control (Indonesia) and World Health Organization
(WHO).
World
Trade Organisation agreements: implications for equity and health
in Southern Africa, 2000.
G. Munot / Equinet Policy Series, Regional
Network for Equity in Health in Southern Africa
(EQUINET) and Southern African Development Community (SADC) Health
Sector Co-ordinating Unit, N°4.
1999
Essential
drugs in the new international economic environment, 1999.
Authors: G. Velasquez, P. Boulet / Bulletin of the World
Health Organization, Vol. 77, N°3.
Globalization
and Access to Drugs. Perspectives on the WTO/TRIPS Agreement,
1999.
Authors: G. Velasquez, P. Boulet / WHO Health Economics and
Drugs, DAP Series, N°7.
Intellectual
Property Rights and the Pharmaceutical Industry The Consequence
of Incomplete Protection, 1999.
Author: William McArthur / in Competitive Strategies for
the Protection of Intellectual Property, edited by Owen Lippert,
The Fraser Institute, Vancouver, Canada, pp. 85-104.
L'OMS
se penche sur les rapports entre commerce et produits pharmaceutiques,
1999.
Valery Abramov / Organisation Mondiale de la Santé
(OMS).
TRIPS
and Pharmaceuticals, 1999.
Eva Ombaka / Echoes, the World Council of
Churches' cluster on "Issues and Themes", Justice, Peace and Creation
team.
1998
Can
patents deter innovation? The anticommons in biomedical research,
1998.
Authors: M.A. Heller, R.S Eisenberg / Science, N°280,
pp. 698-701.
Pharmaceuticals:
the role of biotechnology and patents, 1998.
Author: J. Dumoulin, J./ Biotechnology and Development
Monitor, N°35, p.13-15
The
Introduction of Pharmaceutical Product Patents in India: Heartless
Exploitation of the Poor and Suffering, 1998.
Author: J. Olson Lanjouw / National Bureau of Economic Research
Working Paper, N°6366
1997
Health
Economics: The Uruguay Round and Drugs, 1997.
Author: Carlos M. Correa / WHO.
1996
Product
Patent Reform and its Impact on Korea's Pharmaceutical Industry,
1996.
Authors: Sumner J. La Croix, Akihiko Kawaura / International
Economic Journal, Vol. 10, N°1, Spring 1996.
1995
Alternative
Drug Pricing Policies in the Americas, 1995.
Author: A.Z. Sarmiento / Health Economics and Drugs, DAP Series,
WHO, N°1. |
|
|
|
|
